Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > ARCHIVE
ARCHIVE
- Sysmex, IRC Strengthen Cooperative Relationship
April 9, 2001
- Korosho to Announce Name of Generics Approved Soon after Approval
April 9, 2001
- Medical Divece News in Brief
April 9, 2001
- Rush to Change Approvals for Products Containing Cattle-Derived Materials
April 9, 2001
- JIRA to Propose Introduction of Medical Devices Law
April 9, 2001
- Bringing ICH Agreement to Asia: 3rd IFPMA Asian Regulatory Conference
April 9, 2001
- NEC Develops Home Health Management System Using Internet
April 9, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
April 9, 2001
- Medical Device Industry to Prohibit Financial Support for Social Gatherings of Medical Institutions
April 9, 2001
- Bayer's Pharma Sales Reach \102 Billion: Mr Kleedehn
April 9, 2001
- New Compulsory Standards to Be Introduced for Respirators
April 9, 2001
- BUSINESS NEWS IN BRIEF
April 9, 2001
- World News in Brief
April 9, 2001
- Eisai Signs Research Contract with Prof. Yanagisawa of Texas University
April 9, 2001
- Hp Eradication Saves 320 Bil. in Medical Expenses in 5 Years: Takeda Seminar
April 2, 2001
- BULLETIN
April 2, 2001
- Osteo Genesis Starts Developing Bone Regeneration Technology
April 2, 2001
- BUSINESS NEWS IN BRIEF
April 2, 2001
- MediBIC Licenses Haplotyping Technology from Genaissance
April 2, 2001
- Toho Transfers Business to Affiliated Companies to Increase Efficiency
April 2, 2001
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…